254 related articles for article (PubMed ID: 28167836)
1. Autism-associated Dyrk1a truncation mutants impair neuronal dendritic and spine growth and interfere with postnatal cortical development.
Dang T; Duan WY; Yu B; Tong DL; Cheng C; Zhang YF; Wu W; Ye K; Zhang WX; Wu M; Wu BB; An Y; Qiu ZL; Wu BL
Mol Psychiatry; 2018 Mar; 23(3):747-758. PubMed ID: 28167836
[TBL] [Abstract][Full Text] [Related]
2. DYRK1A-haploinsufficiency in mice causes autistic-like features and febrile seizures.
Raveau M; Shimohata A; Amano K; Miyamoto H; Yamakawa K
Neurobiol Dis; 2018 Feb; 110():180-191. PubMed ID: 29223763
[TBL] [Abstract][Full Text] [Related]
3. Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID.
van Bon BW; Coe BP; Bernier R; Green C; Gerdts J; Witherspoon K; Kleefstra T; Willemsen MH; Kumar R; Bosco P; Fichera M; Li D; Amaral D; Cristofoli F; Peeters H; Haan E; Romano C; Mefford HC; Scheffer I; Gecz J; de Vries BB; Eichler EE
Mol Psychiatry; 2016 Jan; 21(1):126-32. PubMed ID: 25707398
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of β-Tubulin by the Down Syndrome Kinase, Minibrain/DYRK1a, Regulates Microtubule Dynamics and Dendrite Morphogenesis.
Ori-McKenney KM; McKenney RJ; Huang HH; Li T; Meltzer S; Jan LY; Vale RD; Wiita AP; Jan YN
Neuron; 2016 May; 90(3):551-63. PubMed ID: 27112495
[TBL] [Abstract][Full Text] [Related]
5. Impaired development of neocortical circuits contributes to the neurological alterations in DYRK1A haploinsufficiency syndrome.
Arranz J; Balducci E; Arató K; Sánchez-Elexpuru G; Najas S; Parras A; Rebollo E; Pijuan I; Erb I; Verde G; Sahun I; Barallobre MJ; Lucas JJ; Sánchez MP; de la Luna S; Arbonés ML
Neurobiol Dis; 2019 Jul; 127():210-222. PubMed ID: 30831192
[TBL] [Abstract][Full Text] [Related]
6. Dyrk1a Mutations Cause Undergrowth of Cortical Pyramidal Neurons via Dysregulated Growth Factor Signaling.
Levy JA; LaFlamme CW; Tsaprailis G; Crynen G; Page DT
Biol Psychiatry; 2021 Sep; 90(5):295-306. PubMed ID: 33840455
[TBL] [Abstract][Full Text] [Related]
7. Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A.
Bronicki LM; Redin C; Drunat S; Piton A; Lyons M; Passemard S; Baumann C; Faivre L; Thevenon J; Rivière JB; Isidor B; Gan G; Francannet C; Willems M; Gunel M; Jones JR; Gleeson JG; Mandel JL; Stevenson RE; Friez MJ; Aylsworth AS
Eur J Hum Genet; 2015 Nov; 23(11):1482-7. PubMed ID: 25920557
[TBL] [Abstract][Full Text] [Related]
8. Zebrafish knockout of Down syndrome gene,
Kim OH; Cho HJ; Han E; Hong TI; Ariyasiri K; Choi JH; Hwang KS; Jeong YM; Yang SY; Yu K; Park DS; Oh HW; Davis EE; Schwartz CE; Lee JS; Kim HG; Kim CH
Mol Autism; 2017; 8():50. PubMed ID: 29021890
[TBL] [Abstract][Full Text] [Related]
9. Dyrk1A negatively regulates the actin cytoskeleton through threonine phosphorylation of N-WASP.
Park J; Sung JY; Park J; Song WJ; Chang S; Chung KC
J Cell Sci; 2012 Jan; 125(Pt 1):67-80. PubMed ID: 22250195
[TBL] [Abstract][Full Text] [Related]
10. DYRK1A mutations in two unrelated patients.
Ruaud L; Mignot C; Guët A; Ohl C; Nava C; Héron D; Keren B; Depienne C; Benoit V; Maystadt I; Lederer D; Amsallem D; Piard J
Eur J Med Genet; 2015 Mar; 58(3):168-74. PubMed ID: 25641759
[TBL] [Abstract][Full Text] [Related]
11. Global kinome profiling reveals DYRK1A as critical activator of the human mitochondrial import machinery.
Walter C; Marada A; Suhm T; Ernsberger R; Muders V; Kücükköse C; Sánchez-Martín P; Hu Z; Aich A; Loroch S; Solari FA; Poveda-Huertes D; Schwierzok A; Pommerening H; Matic S; Brix J; Sickmann A; Kraft C; Dengjel J; Dennerlein S; Brummer T; Vögtle FN; Meisinger C
Nat Commun; 2021 Jul; 12(1):4284. PubMed ID: 34257281
[TBL] [Abstract][Full Text] [Related]
12. DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A): a gene with dosage effect during development and neurogenesis.
Dierssen M; de Lagrán MM
ScientificWorldJournal; 2006 Jun; 6():1911-22. PubMed ID: 17205196
[TBL] [Abstract][Full Text] [Related]
13. The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo.
Trovò L; Fuchs C; De Rosa R; Barbiero I; Tramarin M; Ciani E; Rusconi L; Kilstrup-Nielsen C
Neurobiol Dis; 2020 May; 138():104791. PubMed ID: 32032735
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of dual specificity kinase activity of DYRK1A.
Walte A; Rüben K; Birner-Gruenberger R; Preisinger C; Bamberg-Lemper S; Hilz N; Bracher F; Becker W
FEBS J; 2013 Sep; 280(18):4495-511. PubMed ID: 23809146
[TBL] [Abstract][Full Text] [Related]
15. DYRK1A and cognition: A lifelong relationship.
Arbones ML; Thomazeau A; Nakano-Kobayashi A; Hagiwara M; Delabar JM
Pharmacol Ther; 2019 Feb; 194():199-221. PubMed ID: 30268771
[TBL] [Abstract][Full Text] [Related]
16. Clinical phenotype of ASD-associated
Earl RK; Turner TN; Mefford HC; Hudac CM; Gerdts J; Eichler EE; Bernier RA
Mol Autism; 2017; 8():54. PubMed ID: 29034068
[TBL] [Abstract][Full Text] [Related]
17. DYRK1A regulates Hap1-Dcaf7/WDR68 binding with implication for delayed growth in Down syndrome.
Xiang J; Yang S; Xin N; Gaertig MA; Reeves RH; Li S; Li XJ
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1224-E1233. PubMed ID: 28137862
[TBL] [Abstract][Full Text] [Related]
18. The Down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4.
Sitz JH; Baumgärtel K; Hämmerle B; Papadopoulos C; Hekerman P; Tejedor FJ; Becker W; Lutz B
Neuroscience; 2008 Dec; 157(3):596-605. PubMed ID: 18938227
[TBL] [Abstract][Full Text] [Related]
19. Dyrk1A influences neuronal morphogenesis through regulation of cytoskeletal dynamics in mammalian cortical neurons.
Martinez de Lagran M; Benavides-Piccione R; Ballesteros-Yañez I; Calvo M; Morales M; Fillat C; Defelipe J; Ramakers GJ; Dierssen M
Cereb Cortex; 2012 Dec; 22(12):2867-77. PubMed ID: 22215728
[TBL] [Abstract][Full Text] [Related]
20. The neurodevelopmental disorder risk gene
Willsey HR; Xu Y; Everitt A; Dea J; Exner CRT; Willsey AJ; State MW; Harland RM
Development; 2020 Jun; 147(21):. PubMed ID: 32467234
[No Abstract] [Full Text] [Related]
[Next] [New Search]
